Sun, Apr 20, 2014, 4:58 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

ms.wardcleaver 213 posts  |  Last Activity: Apr 16, 2014 10:17 AM Member since: Jul 5, 2012
  • Reply to

    1 American $, then .75

    by vogtej Jan 23, 2014 12:08 PM
    ms.wardcleaver ms.wardcleaver Jan 23, 2014 12:35 PM Flag

    CHTP had a positive panel review the first time around. Haven't you read the FDA notes???? The reviewer is recommending a CRL! I would be very surprised if they get approved. Sorry, but you haven't done your due diligence on CHTP and IGXT is NO COMPARSION!

    Sentiment: Strong Buy

  • Most biotechs run up with outrageous market caps, IGXT hasn't run at all and its market cap is still severely discounted at only $62M. Traders may shift the price down or sell out on approval, but this price is going up this year, not down. This stock his headed to $10 by year end. OBXT is another hidden gem with huge upside coming this year end and has a lot of attention already. IGXT has a lot of room to grow in market cap and pps. This is a buy hold.

    Sentiment: Strong Buy

  • Reply to

    1 American $, then .75

    by vogtej Jan 23, 2014 12:08 PM
    ms.wardcleaver ms.wardcleaver Jan 23, 2014 12:29 PM Flag

    This is NO comparison to CHTP! CHTP was denied approval once before and probably won't get approved again. IGXT is for film delivery of an already approved drug. Your post is shows severe ignorance!

  • ms.wardcleaver ms.wardcleaver Jan 23, 2014 11:53 AM Flag

    Daily profit taking. Probably jump up again before 2 PM. I expect big moves up next week before Feb.3

    Sentiment: Strong Buy

  • Expect $8 -$10 by year end with ED film approval. Market cap of $60M right now is way way undervalued. Should be more like $250M right now or $3.75 a share.

    Sentiment: Strong Buy

  • Film delivery in the mouth is faster into the system - closer to head- therefore closer to migraine and absorbed quicker than in the digestive tract or a subcutaneous injection. The charts on the slide presentation are not about delivery, the are about the drug in the blood plasma levels after the drug is absorbed into the blood stream. The film is absorbed FASTER, therefore it begins to work QUICKER, therefore the film is the better "mousetrap". To a migraine sufferer, 5, 10, 15 minutes quicker than tablet or injection is a BIG deal and this film will gain market share over tablet and injection and may just become standard of care. Film for ED will become standard delivery and wipe out tablet production. This company is a GOLD mine and GROSSLY undervalued. 80 cents a share is a JOKE! LOL LOL! This is worth $4.00 right now all day long and will be $10 next year if not higher. The management team will up list this to NASDAQ in no time OR they will be bought out - either will happen this year. HOLD LONG AND STRONG GLTA!

    Sentiment: Strong Buy

  • ms.wardcleaver ms.wardcleaver Jan 21, 2014 3:29 PM Flag

    All public companies that trade OTC desire to up list, they don't have to state it, it is a given. They have to meet several requirement to be able to up list one is that they must maintain over $1.00 share price. With this approval, the will now be able to maintain over $1.00 and they should easily meet the other requirements as well. You need to do some due diligence. The new company president was brought in to expand the company and that ALWAYS includes getting the stock on a bigger exchange and getting the stock into the hands of institutional investors.

    Sentiment: Strong Buy

  • ms.wardcleaver ms.wardcleaver Jan 21, 2014 12:51 PM Flag

    Oh, I don't underestimate the Chairman at all. It is just a good sign when top management is expanding and they are bringing in experienced people to lead growth.

    Sentiment: Strong Buy

  • Reply to

    Still waiting for run up

    by titusmabon Jan 21, 2014 12:04 PM
    ms.wardcleaver ms.wardcleaver Jan 21, 2014 12:24 PM Flag

    Its most likely because this is OTC. May not move until approval and then double overnight - that is OTC market place - violent moves up and down - however, I expect this to be a violent move up.

    Sentiment: Strong Buy

  • ms.wardcleaver ms.wardcleaver Jan 21, 2014 12:22 PM Flag

    Yes, this company doesn't have the huge debt burden/arrangements that most bio-techs have. This company has a clean balance sheet and will be profitable this year. Very exciting times for this company! The shift to new management is also a sign that they are preparing for serious new growth. New company president is a refreshing and welcome change/addition.

    Sentiment: Strong Buy

  • If this stock wasn't OTC, it would be $3.00 right now! The approval on Feb. 3rd is just the beginning of a pivotal year for this company. Stock price will easily be $1.50 minimum after approval is announced. Stock will get uplisted to NASDAQ in the first half of 2014 and the stock price will explode. I am holding this one for a couple years, too much long term potential. I can easily calculate out a $10 stock price in one to two years.

    Sentiment: Strong Buy

  • Reply to

    How can this be?

    by larrymcousins Jan 21, 2014 11:56 AM
    ms.wardcleaver ms.wardcleaver Jan 21, 2014 12:14 PM Flag

    Newbe, huh?

  • Migraine Film will be more popular than pills because it works faster. Film will be more popular than syringes because people hate needles and injections plus can't go through airport with needles and film is faster. Film will be more popular than nasal spray because nasal sprays burn, drip; can't go through airport with nasal spray and film is faster. Film will capture more market share for Migraine. Now for Erectile dysfunction, film will dominate over pill if not replace - all men would rather have a film in their wallet especially on a date or in a bar - so much easier to take the film and get ready for sex. This stock will pop on approval for migraine, but the prize is erectile dysfunction.

    Sentiment: Strong Buy

NAVB
1.660.00(0.00%)Apr 17 4:06 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST